fig2
![Glycogen synthase kinase 3β biology in bone and soft tissue sarcomas](https://image.oaes.cc/75464bb3-86d4-4087-aabd-d1cf45ea8fdc/3820.fig.2.jpg)
Figure 2. Causative involvement of GSK3β in upfront sarcoma therapies and in the adverse events associated with therapy. →: promoting; —|: suppressive; dotted line: hypothetical effect; NKT: natural killer T; MSCs, mesenchymal stem cells; CAR: chimeric antigen receptor; CNS: central nervous system; GSK3β: glycogen synthase kinase 3β